WHWKNASDAQ Global Market·USD·Closed·Healthcare · Biotechnology
Whitehawk Therapeutics Inc
$4.62−$0.25 · −5.13%day vs prior
Mkt Cap · USD
263.38M
P/E · TTM
-4.1
Div Yield · ann
–
52-week
$1.76 – $5.50
at 77% of range
Whitehawk Therapeutics Inc. is a biopharmaceutical enterprise currently undergoing clinical trials. This company specializes in crafting highly targeted treatment options for cancers that are identified by distinct genetic profiles.
Loading chart data...
Signal state